Development of prostate specific antigen (PSA) screening nomograms for 15-year prediction of prostate cancer diagnosis (PCDx), mortality (PCM), and all-cause mortality (ACM)

2018 ◽  
Vol 17 (2) ◽  
pp. e379
Author(s):  
S. Carlsson ◽  
M. Brooks ◽  
A. Zajichek ◽  
K. Chagin ◽  
J. Hugosson ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Prostate Specific Antigen ◽  
Cancer Diagnosis ◽  
Specific Antigen ◽  
Prostate Cancer Diagnosis ◽  
Psa Screening ◽  
All Cause Mortality

Glycosylated Biomarker Sensors: Advancements in Prostate Cancer Diagnosis

2021 ◽  
Author(s):  
Siti Fatimah Abd Rahman ◽  
Mohd Khairuddin Md Arshad ◽  
Subash Gopinath ◽  
Mohamad Faris Mohamad Fathil ◽  
Frédéric Sarry ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Prostate Specific Antigen ◽  
Cancer Diagnosis ◽  
Gold Standard ◽  
Specific Antigen ◽  
Prostate Cancer Diagnosis ◽  
Standard Methods ◽  
Psa Screening

Prostate cancer is currently diagnosed using the conventional gold standard methods using prostate-specific antigen (PSA) as a selective biomarker. However, lack of precision in PSA screening has resulted in needless...

UP.42: Correlation of Pre-operative Prostate Specific Antigen (PSA) With Gleason Grading in Prostate Cancer Diagnosis

Urology ◽  
2008 ◽  
Vol 72 (5) ◽  
pp. S122-S123
Author(s):  
K. Gyasi-Sarpong ◽  
K. Boateng ◽  
K. Aboah ◽  
P. Opoku ◽  
M. Adu-Gyamfi
Keyword(s):  
Prostate Cancer ◽  
Prostate Specific Antigen ◽  
Cancer Diagnosis ◽  
Specific Antigen ◽  
Prostate Cancer Diagnosis ◽  
Gleason Grading
Sign in / Sign up

Export Citation Format

Share Document